1GETI:BIT
Getinge publ AB
€17.70
arrow_upward
+1.46%(+0.26) 1D
May 19, 10:44:40 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1GETI...
Mkt. cap
48.01B
Avg. vol.
17.00
Volume
0.00
52-wk high
€22.59
52-wk low
€16.09
No. of employees
12K
Mkt. cap
48.01B
Avg. vol.
17.00
Volume
0.00
52-wk high
€22.59
52-wk low
€16.09
No. of employees
12K
News stories
From sources across the web
AD HOC NEWS
·
4 hours ago
Getinge AB stock (SE0000202624): shares steady on Nasdaq Stockholm as new Vasoview Hemopro 3 launch
Simply Wall Street
·
1 day ago
Assessing Getinge (OM:GETI B) Valuation After Recent Choppy Share Price Performance
Ad Hoc News
·
1 day ago
Getinge AB stock (SE0000202624): shares little changed as investors eye analyst views after Q1 updat
Ad Hoc News
·
3 days ago
Getinge AB stock (SE0000202624): shares steady as investors look beyond recent earnings
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
AI content may include mistakes. Learn more